Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.7%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check54 days agoChange DetectedThe webpage has been updated to include new details about the study on Crohn's disease, specifically regarding the treatment protocol with risankizumab, and the involvement of Boehringer Ingelheim as a collaborator. Additionally, the revision number has been updated to v2.15.0.SummaryDifference16%
- Check68 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check76 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.